Bellerophon Therapeutics, Inc. (11)

Browse by Contract Category

Contracts

Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2021)
Underwriting Agreement by and between Bellerophon Therapeutics, Inc. and Jefferies LLC, dated May 18, 2020 (Filed With SEC on May 20, 2020)
Advisory Agreement, by and between Bellerophon Therapeutics, Inc. and Angel Pond Capital LLC, dated May 18, 2020 (Filed With SEC on May 20, 2020)
Open Market Sale AgreementSM, dated July 17, 2020, by and between Bellerophon Therapeutics, Inc. and Jefferies LLC (Filed With SEC on July 17, 2020)
Subscription Agreement by and between Bellerophon Therapeutics, Inc. and Puissance Life Science Opportunities Fund VI, dated May 18, 2020 (Filed With SEC on May 20, 2020)
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 6, 2020)
Form of Engagement Letter (Filed With SEC on March 30, 2020)
Form of Securities Purchase Agreement, dated as of March 30, 2020, by and among Bellerophon Therapeutics, Inc. and the Investors (Filed With SEC on March 30, 2020)
Binding Term Sheet and Agreement for Line of Credit Facility dated December 16, 2019 between the Company and the signatories identified therein (Filed With SEC on December 17, 2019)
Form of Warrant Amendment, dated June 28, 2019 (Filed With SEC on July 1, 2019)
Underwriting Agreement, dated January 23, 2019, by and between Bellerophon Therapeutics, Inc. and H.C. Wainwright & Co (Filed With SEC on January 23, 2019)